CRUSH PAD: Real-world Outcomes Following Use of the Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions
Diseases of the Cardiovascular System
What is the purpose of this trial?
The primary goal of the study is to obtain effect size data on the use of Shockwave Intravascular Lithotripsy (IVL) technology in calcified common femoral lesions in patients with peripheral artery disease for a series of endpoints, including target lesion revascularization and health status, to enable future planning of comparative effectiveness research.
- Ages18 years and older
- Trial withShockwave Medical Inc.
- Start Date09/13/2021
- End Date12/31/2023
- Last Updated12/17/2021
- Study HIC#2000031113